Fresenius Medical Care's subsidiary, Xenios AG, has launched Xenios 2.0, a new system for extracorporeal life support (ECLS) ...

ESET has been recognized as a Strategic Leader for the fourth time in the AV-Comparatives 2024 Endpoint Prevention and Response (EPR) Comparative ...

Belgium and France meet again on Monday with the second of their two UEFA Nations League games in Brussels having also met at ...

GSK Plc’s experimental drug to treat a common inflammatory nasal condition showed positive results in two late-stage trials ...

WHEN UK Prime Minister Keir Starmer welcomes business leaders to a major investment summit in London today, his message to ...

GSK settles 93% of Zantac lawsuits with a $2.2 billion payout, easing investor concerns. However, doubts over its future ...

(Sharecast News) - London stocks had edged lower by midday on Friday as investors mulled the latest UK GDP data and awaited an update on China's stimulus plans. The FTSE 100 was down 0.2% at 8,221.11.

As one of the largest pharmaceutical and vaccine companies, GSK has used its vast resources to create the next generation of healthcare treatments. The company's innovative new product lineup and ...

European stocks closed weak on Thursday, as hotter-than-expected U.S. consumer price inflation data has further offset optimism the ...

Value-for-money UPC is worth it says GSK corporate counsel | Court offers alternative to costly US litigation | Head of ...

GSK's share price rose 6% after settling 93% of Zantac cases, impacting Q3 earnings; forward non-GAAP P/E remains reasonable ...

The settlement, which is at the low end of Jefferies analysts’ $2 billion to $3.5 billion estimate, will resolve 93% of the ...